8 results on '"Preuner S"'
Search Results
2. The EuroChimerism concept for a standardized approach to chimerism analysis after allogeneic stem cell transplantation.
- Author
-
Lion, T, Watzinger, F, Preuner, S, Kreyenberg, H, Tilanus, M, de Weger, R, van Loon, J, de Vries, L, Cavé, H, Acquaviva, C, Lawler, M, Crampe, M, Serra, A, Saglio, B, Colnaghi, F, Biondi, A, van Dongen, J J M, van der Burg, M, Gonzalez, M, and Alcoceba, M
- Subjects
CHIMERISM ,STEM cell transplantation ,POLYMERASE chain reaction ,BIOLOGICAL assay ,HEMATOPOIETIC stem cells - Abstract
Hematopoietic stem cell transplantation is becoming an increasingly important approach to treatment of different malignant and non-malignant disorders. There is thus growing demand for diagnostic assays permitting the surveillance of donor/recipient chimerism posttransplant. Current techniques are heterogeneous, rendering uniform evaluation and comparison of diagnostic results between centers difficult. Leading laboratories from 10 European countries have therefore performed a collaborative study supported by a European grant, the EuroChimerism Concerted Action, with the aim to develop a standardized diagnostic methodology for the detection and monitoring of chimerism in patients undergoing allogeneic stem cell transplantation. Following extensive analysis of a large set of microsatellite/short tandem repeat (STR) loci, the EuroChimerism (EUC) panel comprising 13 STR markers was established with the aim to optimally meet the specific requirements of quantitative chimerism analysis. Based on highly stringent selection criteria, the EUC panel provides multiple informative markers in any transplant setting. The standardized STR-PCR tests permit detection of donor- or recipient-derived cells at a sensitivity ranging between 0.8 and 1.6%. Moreover, the EUC assay facilitates accurate and reproducible quantification of donor and recipient hematopoietic cells. Wide use of the European-harmonized protocol for chimerism analysis presented will provide a basis for optimal diagnostic support and timely treatment decisions. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
3. Early recipient chimerism testing in the T- and NK-cell lineages for risk assessment of graft rejection in pediatric patients undergoing allogeneic stem cell transplantation.
- Author
-
Breuer, S, Preuner, S, Fritsch, G, Daxberger, H, Koenig, M, Poetschger, U, Lawitschka, A, Peters, C, Mann, G, Lion, T, and Matthes-Martin, S
- Subjects
- *
TRANSPLANTATION of organs, tissues, etc. , *STEM cells , *T cells , *HEMATOPOIETIC stem cells , *PEDIATRIC therapy , *PEDIATRIC diagnosis - Abstract
Timely diagnosis of impending graft rejection is crucial for effective therapeutic intervention after allogeneic hematopoietic stem cell transplantation (SCT). We have investigated the predictive potential of early leukocyte subset-specific chimerism for graft loss in children undergoing SCT. In total, 192 pediatric patients transplanted for the treatment of malignant and non-malignant diseases after reduced-intensity or myeloablative conditioning were investigated. Surveillance of lineage-specific chimerism was initiated upon first appearance of leukocyte counts amenable to cell sorting. Graft rejection occurred in 23 patients between 24 and 492 days post-transplant (median 63 days). The first chimerism analysis of T and NK cells performed at a median of 20 days after SCT identified three different risk groups that were independent from the conditioning regimen: recipient chimerism (RC) levels in T cells below 50% indicated a very low risk of rejection (1.4%), whereas high levels of RC (>90%) both in T and NK cells heralded graft loss in the majority of patients (90%) despite therapeutic interventions. RC >50% in T cells and 90% in NK cells defined an intermediate-risk group in which timely immunotherapy frequently prevented rejection. Early assessment of T- and NK-cell chimerism can therefore be instrumental in the risk assessment and therapeutic management of imminent graft rejection. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
4. Standardization of DNA isolation from low cell numbers for chimerism analysis by PCR of short tandem repeats.
- Author
-
Van der Burg, M., Kreyenberg, H., Willasch, A., Barendregt, B. H., Preuner, S., Watzinger, F., Lion, T., Roosnek, E., Harvey, J., Alcoceba, M., Díaz, M. G., Bader, P., and Van Dongen, J. J. M.
- Subjects
CHIMERISM ,STEM cell transplantation ,POLYMERASE chain reaction ,PROTOCOL analysis (Cognition) - Abstract
Analysis of short tandem repeats (STR) by PCR analysis is routinely used in chimerism diagnostics to monitor donor engraftment and to diagnose relapse. Some applications require chimerism analysis of low cell numbers, but no standardized protocol is available for DNA isolation from 1000 to 30 000 cells. The EU-supported EuroChimerism Consortium (project QLRT-2001-01485) selected four different protocols for 'small-scale' DNA isolation, which were tested by six laboratories for their ability to recover reproducible amounts of good quality DNA, suited for PCR-based STR analysis. The protocols included two direct lysis methods with and without detergents and proteinase K, and two commercial column-based kits. The direct lysis method using detergents and proteinase K showed the highest DNA recovery and the best performance in the multiplex PowerPlex16 STR assay. DNA isolated with this method also showed the highest sensitivity in chimerism analysis using singleplex PCR reactions of EuroChimerism STR markers. Sensitivity was reached ranging from 1 to 20% of recipient cells in a donor background. In conclusion, the direct lysis method using detergents and proteinase K is a standardized DNA isolation method well suited for chimerism studies on low cell numbers. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
5. Diagnosis of invasive fungal infections by a real-time panfungal PCR assay in immunocompromised pediatric patients.
- Author
-
Landlinger, C., Preuner, S., Bašková, L., van Grotel, M., Hartwig, N. G., Dworzak, M., Mann, G., Attarbaschi, A., Kager, L., Peters, C., Matthes-Martin, S., Lawitschka, A., van den Heuvel-Eibrink, M. M., and Lion, T.
- Subjects
- *
INTRODUCED fungi , *MYCOSES , *PEDIATRICS , *PATHOGENIC fungi , *ZYGOMYCETES - Abstract
Invasive fungal disease (IFD) is a life-threatening event in immunocompromised patients, and there is an urgent need for reliable screening methods facilitating rapid and broad detection of pathogenic fungi. We have established a two-reaction real-time PCR assay permitting highly sensitive detection of more than 80 fungal pathogens, covering a large spectrum of moulds, yeasts and Zygomycetes. To assess the clinical potential of the assay, more than 600 consecutive specimens from 125 pediatric patients carrying a high risk of IFD were analyzed. An excellent correlation between PCR positivity and the presence of proven, probable or possible fungal infection according to the European Organization for Research and Treatment of Cancer criteria was demonstrated, as revealed by the sensitivity of the assay of 96% (95% CI: 82-99%). The negative predictive value of the panfungal PCR assay presented was 98% (95% CI: 90-100%), while the specificity and the positive predictive value were 77% (95% CI: 66-85%) and 62% (95% CI: 47-75%), respectively. The results indicate that molecular screening of patients during febrile neutropenic episodes by the assay presented could help prevent unnecessary toxicity resulting from empirical antifungal treatment in individuals who may not be at risk of imminent fungal disease. Our observations raise the possibility that rapid species identification may be required to increase the positive predictive value for impending fungus-related disease. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
6. Monitoring of adenovirus load in stool by real-time PCR permits early detection of impending invasive infection in patients after allogeneic stem cell transplantation.
- Author
-
Lion, T., Kosulin, K., Landlinger, C., Rauch, M., Preuner, S., Jugovic, D., Pötschger, U., Lawitschka, A., Peters, C., Fritsch, G., and Matthes-Martin, S.
- Subjects
ADENOVIRUS diseases ,TRANSPLANTATION of organs, tissues, etc. ,VIREMIA ,FECES ,INFECTION - Abstract
Invasive adenovirus (AdV) infections are associated with high morbidity and mortality in allogeneic stem cell transplant recipients. We observed that molecular detection of the virus in stool specimens commonly precedes AdV viremia, suggesting that intestinal infections may represent a common source of virus dissemination. To address this notion, we have investigated 153 consecutive allogeneic transplantations in 138 pediatric patients by quantitative monitoring of AdV in stool specimens and peripheral blood by a pan-adenovirus real-time (RQ)-PCR approach. AdV was detectable in serial stool specimens in all cases of AdV viremia during the post-transplant course (P<0.0001). The incidence of AdV viremia in individuals with peak virus levels in stool specimens above 1 × 10E6 copies per gram (n=22) was 73% vs 0% in patients with AdV levels in stool specimens below this threshold (n=29; P<0.0001). Serial measurement of AdV levels in stool specimens by RQ-PCR permitted early diagnosis of impending invasive infection with a sensitivity and specificity of 100% (95% confidence interval (CI) 96–100%) and 83% (95% CI 67–92%), respectively. The median time span between detection of AdV loads in stool specimens above 1 × 10E6 copies per gram and first observation of viremia was 11 days (range 0–192). Quantitative monitoring of the AdV load in stool specimens therefore provides a rationale for early initiation of antiviral treatment with the aim of preventing progression to life-threatening invasive infection. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
7. Identification of fungal species by fragment length analysis of the internally transcribed spacer 2 region.
- Author
-
Landlinger, C., Bašková, L., Preuner, S., Willinger, B., Buchta, V., and Lion, T.
- Subjects
PATHOGENIC microorganisms ,FUNGI ,POLYMERASE chain reaction ,ASPERGILLUS ,CANDIDA ,FUSARIUM oxysporum ,SPECIES ,DIAGNOSTIC specimens ,QUANTITATIVE research ,MEDICAL sciences - Abstract
The rapid identification of fungal pathogens in clinical specimens is a prerequisite for timely onset of the most appropriate treatment. The aim of the present study was to develop a sensitive and rapid method for the species-specific identification of clinically relevant fungi. We employed fluorescent polymerase chain reaction (PCR)-fragment length analysis of the highly variable internally transcribed spacer 2 (ITS2) region to identify individual fungal species by their specific amplicon sizes. The specificity of the technique was ascertained by the detailed analysis of 96 strains derived from 60 different human-pathogenic fungal species. To achieve adequate sensitivity for species identification in patients with invasive fungal infection, who often display very low pathogen loads in peripheral blood, the ITS2 region was amplified by semi-nested PCR prior to amplicon-length analysis. Serial specimens from 26 patients with documented fungal infections were investigated. The fungal pathogens identified included different Aspergillus and Candida species, Rhizopus oryzae and Fusarium oxysporum. Fragment length analysis of the ITS2 region upon amplification by semi-nested PCR permits the sensitive identification of fungal species. The technique can be readily implemented in routine diagnostics. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
8. Quantitative monitoring of cell clones carrying point mutations in the BCR–ABL tyrosine kinase domain by ligation-dependent polymerase chain reaction (LD–PCR).
- Author
-
Preuner, S., Denk, D., Frommlet, F., Nesslboeck, M., and Lion, T.
- Subjects
- *
PROTEIN-tyrosine kinases , *POLYMERASE chain reaction , *CHRONIC myeloid leukemia , *TREATMENT of chronic myeloid leukemia , *IMATINIB , *PATIENTS - Abstract
The article discusses the role of tyrosine kinase (TK) inhibitors as the standard treatment for patients with chronic myeloid leukemia (CML). It says that the level of resistance to individual TK inhibitors may vary from slightly reduced sensitivity to total insensitivity. Further, patients treated with imatinib, mutations conferring only moderately impaired sensitivity may be approached by increasing the dose.
- Published
- 2008
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.